Frontlight ResearchEarly access
Trial site
CHU Rangueil
- 15running trials
- 6closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Obesity6 trials
- Liver and biliary tract cancer4 trials
- Chronic kidney disease3 trials
- Neuroendocrine tumours3 trials
- Coronary artery disease2 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Peripheral artery disease2 trials
- Stroke2 trials
- Type 1 diabetes2 trials
- Type 2 diabetes2 trials
- Ulcerative colitis2 trials
- Bladder cancer1 trial
- and 5 more
- Phase
- Phase 38 trials
- Phase 22 trials
- Phase 2/32 trials
- Status
- Recruiting9 trials
- Active, not recruiting6 trials
- Completed5 trials
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company8 trials
- Federation Francophone de Cancerologie Digestive3 trials
- Hospices Civils de Lyon2 trials
- Boston Scientific Corporation1 trial
- Centre Hospitalier de PAU1 trial
- and 6 more
Running trials
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Liver and biliary tract cancer2 recruiting
- Obesity2 recruiting
- Ulcerative colitis2 recruiting
- Bladder cancer1 recruiting
- Chronic kidney disease1 recruiting
- Colorectal cancer1 recruiting
- Coronary artery disease1 recruiting
- Crohn's disease1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Neuroendocrine tumours1 recruiting
- Peripheral artery disease1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026